20140530 isbt ttbi survey · 2014. 12. 29. · 20140530_isbt_ttbi_survey author: edward chew...
TRANSCRIPT
25/08/2014
1
Update on ISBT Interna/onal Survey on Transfusion-‐transmi9ed Bacterial Infec/ons
Edward Chew & Erica Wood
On behalf of the WPs on TTID and HV
• Rationale & construction of survey • Demographics of respondents
• Blood supplier(s)
• Haemovigilance programmes
• Transfusion-transmitted bacterial infection (TTBI)
• Bacterial contamination of blood components
Interna/onal Survey on TTBI
25/08/2014
2
Interna/onal Survey on TTBI
• Variability in defini/ons of TTBI • Variability in approach to:
– Ini/al inves/ga/ons – Confirmatory tes/ng – Repor/ng of events – Preven/ve measures
Interna/onal Survey on TTBI • Joint initiative of:
– Haemovigilance WP – TTID WP
• Assessment of definitions and current practices in prevention, diagnosis, management and reporting
• Initial draft questionnaire with feedback from WP members
• Wide distribution of final questionnaire • First survey results reported to WP at ISBT
Congress in June 2013 • Additional contacts emailed December 2013
25/08/2014
3
• Rationale & construction of survey • Demographics of respondents
• Blood supplier(s)
• Haemovigilance programme
• Transfusion-transmitted bacterial infection (TTBI)
• Bacterial contamination of blood components
• Future directions
Interna/onal Survey on TTBI
Interna/onal Survey on TTBI Demographics of respondents
• 212 par/cipants in 73 countries invited to par/cipate
• 58 responses from 39 countries • Good representa/on of countries & organisa/ons • Some responses joint submissions from members
of the same organisa/on
25/08/2014
4
Interna/onal Survey on TTBI Demographics of respondents
39 countries
Interna/onal Survey on TTBI Demographics of respondents
• 58 respondents • 51 medical • 7 non-‐medical
• 27 countries had more than 1 blood supplier
25/08/2014
5
• Rationale & construction of survey • Demographics of respondents
• Blood supplier(s)
• Haemovigilance programme
• Transfusion-transmitted bacterial infection (TTBI)
• Bacterial contamination of blood components
• Future directions
Interna/onal Survey on TTBI
Interna/onal Survey on TTBI Haemovigilance Programmes
0 2 4 6 8 10 12 14 16 18 20
Na/onal Haemovigilance Programme
Na/onal & Regional Haemovigilance Programme
Regional Haemovigilance Programme
No Haemovigilance Programme
6
3
1
14
2
1
12
Number of Countries
Haemovigilance Programmes according to Regional/Na9onal and Voluntary/Mandatory
Voluntary
Mandatory
25/08/2014
6
Interna/onal Survey on TTBI TTBI defini/ons • Standard definition of TTBI available for:
27/58 respondents from 17 countries – Australia – Belgium – Brazil – Canada – Finland – Germany – Japan – Jordan – Morocco – Netherlands (TRIP) – New Zealand – Portugal – Republic of Korea – South Africa – Switzerland – UK (SHOT) – USA (CDC)
1
Revised November 2012
NHSN Biovigilance Component Hemovigilance Module Surveillance Protocol v2.1.2
www.cdc.gov/nhsn
Page 1 of 31 January 2014
National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol
Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention Atlanta, GA, USA
31/03/2014 12:32 amTRIP Hemovigilance definitions
Page 1 of 3https://www.tripnet.nl/pages/en/definities.php
Home | News | Hemovigilance | Biovigilance | Office | Publications | Links Reporting Procedure | Confidentiality Policy | Definitions
Login
TRIP (2008) definitions of transfusion reactions and incidentsNonhemolytic transfusion reaction (NHTR)
Rise in temperature of ≥ 2 o C (with or without rigors/chills) during or in the first two hours after a transfusion,with no other relevant symptoms or signs; OR rigors/chills with or without a rise in temperature within thesame time limits. No evidence (biochemical or blood group serological) for hemolysis, and no alternativeexplanation.
Mild (nonhemolytic) febrile reactionRise in temp. >1°C (<2°C) during or in the first two hours after a transfusion with no other relevant symptomsor signs; optional reporting to TRIP. Hemolysis testing and bacteriology negative if performed.
Acute hemolytic transfusion reactionSymptoms of hemolysis occurring within a few minutes of commencement of until 24 hours subsequent to atransfusion: one or more of the following: fever/chills, nausea/vomiting, back pain, dark or red urine,decreasing blood pressure or laboratory results indicating hemolysis within the same period.Biochemical hemolysis testing positive; bloodgroup serological testing possibly positive; bacteriologynegative.
Delayed hemolytic transfusion reactionSymptoms of hemolysis occurring longer than 24 hours after transfusion to a maximum of 28 days:unexplained drop in hemoglobin, dark urine, fever or chills etc; or biochemical hemolysis within the sameperiod. Biochemical testing and blood group serology confirm this.If new antibodies are found without biochemical confirmation of hemolysis, report as new allo-antibody.
TRALI (Transfusion-related acute lung injury)Dyspnoea and hypoxia within six hours of the transfusion; chest Xray shows bilateral pulmonary infiltrates.There are negative investigations (biochemical or blood-group serological) for hemolysis, bacteriology isnegative and no other explanation exists. Depending on the findings of tests of leukocyte serology, report isclassified as immune-mediated or unknown cause.
Transfusion-associated circulatory overload (TACO)Dyspnoea, orthopnoea, cyanosis, tachycardia >100/min. or raised central venous pressure (one or more ofthese signs) within six hours of transfusion, usually in a patient with compromised cardiac function. Chest X-ray consistent.
Anaphylactic transfusion reactionRapidly developing reaction occurring within a few seconds to minutes after the start of transfusion, withfeatures such as airway obstruction, in and expiratory stridor, fall in blood pressure ≥ 20mm Hb systolicand/or diastolic, nausea or vomiting or diarrhoea, possibly with skin rash.Hemolysis testing and bacteriology negative, test for IgA and anti-IgA.
Other allergic reactionAllergic phenomena such as itching, redness or urticaria but without respiratory, cardiovascular orgastrointestinal features, arising from a few minutes of starting transfusion until a few hours after itscompletion. Hemolysis testing and bacteriology negative if performed.
New allo-antibodyAfter receiving a transfusion, demonstration of clinically relevant antibodies against blood cells (irregularantibodies, HLA or HPA antibodies) that were not present previously (as far as is known in that hospital).
Post-transfusion bacteremia/sepsisClinical symptoms of bacteremia/sepsis arising during, directly after or some time subsequent to a bloodtransfusion, for which there is a relevant, positive blood culture of the patient with or without a causal relation
Table of
Assessment of the Reports of Serious Adverse
Transfusion Reactions pursuant to Section 63 c AMG
(Arzneimittelgesetz, German Medicinal Products Act)
// HAEMOVIGILANCE REPORT OF THE PAUL-EHRLICH-INSTITUT //
2010
Federal Institute for Vaccines and Biomedicines
CCDRCCDRCanada Communicable Disease Report
ISSN 1188-4169
Volume: 34S1 January 2008 Supplement
Guideline for Investigation of Suspected Transfusion
Transmitted BacterialContamination
• Rationale & construction of survey • Demographics of respondents
• Blood supplier(s)
• Haemovigilance programme
• Transfusion-transmitted bacterial infection (TTBI)
• Bacterial contamination of blood components
• Future directions
Interna/onal Survey on TTBI
25/08/2014
7
Interna/onal Survey on TTBI Transfusion-‐transmi9ed Bacterial Infec/ons
What clinical symptoms and signs might suggest
or be consistent with a potential case of TTBI?
Interna/onal Survey on TTBI TTBI symptoms
12
20
14
19
26
25
31
17
42
16
38
41
48
19
2
23
21
11
13
8
16
2
23
6
4
1
1
2
1
3
2
1
27
36
20
18
20
18
18
22
14
17
13
13
10
0 10 20 30 40 50 60
No symptoms
Others
Pain at infusion site
Lumbar/back pain
Agita/on and/or confusion
Hypoxia
Shortness of breath
Bradycardia
Tachycardia
Hypertension
Hypotension
Rigors
Fever
Number of responses
Symptoms and signs
Symptoms and signs consistent with a TTBI
Yes
No
Maybe
Not answered
25/08/2014
8
Interna/onal Survey on TTBI TTBI:
• Other symptoms / signs: • Nausea, vomiting • Abdominal pain • Diarrhoea • Oliguria, renal failure • Headache, encephalitis, meningitis • Jaundice • Myalgia, arthralgia • Cyanosis • Shock • Chest pain • DIC • Death
Interna/onal Survey on TTBI
What tests are required / performed to investigate
a suspected clinical case of TTBI?
25/08/2014
9
Interna/onal Survey on TTBI
8
12
6
9
26
26
32
34
44
44
48
17
25
34
27
15
15
10
12
3
3
1
33
21
18
22
17
17
16
12
11
11
9
0 10 20 30 40 50 60 70
Other
Molecular test (eg pulsed-‐field gel electrophoresis)
Urine culture of the recipient
Chest X-‐ray of the recipient
Haemolysis screen of the recipient
Full blood count of the recipient
Blood group & an/body screen of recipient
Gram stain of implicated component
Blood culture of the recipient
Culture of any associated blood component prepared from
Culture of implicated component
Number of responses
Tests
Tests performed for inves9ga9on of a poten9al TTBI
Yes
No
Not answered
Interna/onal Survey on TTBI
• 25 / 37 do not routinely perform molecular tests • Other tests performed:
• Visual inspection (haemolysis) • CRP • Antibiotic testing • Serotyping • Pulsed-field electrophoresis • Sequence comparisons of isolates • Verax PGD testing • Exclude other transfusion reactions
• Imputability for TTBI assigned: • Locally (20 / 46 respondents) • HVP (9 / 46 respondents) • Joint hospital and HVP (13 / 46 respondents) • Other (2) • Not specified (2)
25/08/2014
10
Interna/onal Survey on TTBI
For the purpose of reporting to HV Programmes:
• 32 / 40 respondents differentiate between suspected and confirmed cases
• 30 / 32 report suspected but not confirmed cases to their HV Programmes
• 38 / 40 respondents report confirmed cases to their HV Programmes
• Rationale & construction of survey • Demographics of respondents
• Blood supplier(s)
• Haemovigilance programme
• Transfusion-transmitted bacterial infection (TTBI)
• Bacterial contamination of blood components
• Future directions
Interna/onal Survey on TTBI
25/08/2014
11
Interna/onal Survey on TTBI Bacterial Contamina/on of Blood Components
What measures are in place at the time of blood
collection / preparation to reduce the risk of TTBI?
Interna/onal Survey on TTBI
0 5 10 15 20 25 30 35 40 45 50
Diversion Pouch
Skin Prepara/on
Donor Health Assessment
Donor Ques/onnaire
44
50
43
50
4
6
Measures at the Time of Blood Collec9on / Prepara9on to Reduce Risk of TTBI
Yes
No
25/08/2014
12
Interna/onal Survey on TTBI
Other measures to reduce bacterial contamination: • CRP of donors • Pathogen reduction technology • Short expiry • Visual inspection • Bacterial surveillance of PC / outdated PC • Random culture of blood products
Interna/onal Survey on TTBI
0 5 10 15 20 25 30
Yes
No
Not known
25 3
20
3
2
Rou9ne Screening for Bacterial Contamina9on of Blood Components with a Sample Taken for Tes9ng Prior to Release
Blood Supplier Both
25/08/2014
13
Interna/onal Survey on TTBI Summary
• International survey providing a snapshot of practices around the world
• Variation in TTBI definitions used
• Variation in practices for prevention, management and investigation of TTBI
• Summary of different definitions
• Basis for possible standardised definition in the future
Interna/onal Survey on TTBI Summary